Angiography-derived versus wire-based fractional flow reserve for guiding coronary revascularization: a meta-analysis of randomized controlled trials
Frontiers in Cardiovascular Medicine · 30.10.2026 · 13
DOI: 10.3389/fcvm.2026.1969354 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 30.10.2026. Verfasst von Peng-Yu Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital (The Second Clinical College of …. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Invasive pressure-wire-based fractional flow reserve (FFR) is the reference standard for physiology-guided coronary revascularization, yet it requires pressure-wire equipment and adenosine-induced hyperemia. Angiography-derived FFR enables functional assessment solely from coronary angiograms, while quantitative pooled evidence from patient-level randomized controlled trials (RCTs) remains limited.
Methods
We searched PubMed, Cochrane Library, Embase and Web of Science Core Collection for eligible RCTs comparing angiography-derived FFR-guided versus wire-based FFR-guided revascularization. The primary endpoint was major adverse cardiovascular events (MACE). Pooled risk ratios or mean differences with 95% confidence intervals were calculated. GRADE assessment and trial sequential analysis (TSA) were performed, and publication bias was evaluated by funnel-plot inspection.
Results
Four RCTs involving 6,542 participants were included. No significant difference in MACE was observed between groups (RR 1.07, 95%CI 0.91-1.27). All-cause mortality, cardiac mortality, recurrent myocardial infarction, unplanned revascularization and stent thrombosis were also comparable. Angiography-derived FFR was associated with higher patients-level PCI rate (RR 1.24, 95%CI 1.15-1.33), lesion-level PCI rate (RR 1.24, 95%CI 1.18-1.31) and shorter procedural time (MD −4.09 min, 95%CI −5.76 to −2.43). TSA showed insufficient sample size for most hard clinical endpoints. GRADE certainty varied across endpoints, procedural outcomes were rated high-certainty, while most clinical outcomes were of moderate certainty and stent thrombosis of low certainty.
Conclusions
Relative to wire-based FFR, angiography-derived FFR showed no statistically significant difference in ischaemic-driven clinical outcomes and procedural duration. However, it may increase the likelihood of undergoing PCI. Further large-scale trials with extended follow-up are needed to clarify the long-term implications of this revascularization pattern. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/ , CRD420261479620.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital (The Second Clinical College of North Sichuan Medical College), Nanchong, Sichuan, China.
- The Second Clinical College of North Sichuan Medical College, Nanchong, Sichuan, China.
Zitieren
APA
Zhong, P. Y., Yang, Q. Y., Lei, L., He, L., & Ni, W. (2026). Angiography-derived versus wire-based fractional flow reserve for guiding coronary revascularization: a meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1969354
Vancouver
Zhong PY, Yang QY, Lei L, He L, Ni W. Angiography-derived versus wire-based fractional flow reserve for guiding coronary revascularization: a meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1969354
BibTeX
@article{Zhong2026,
author = {Zhong, Peng-Yu and Yang, Qing-Yi and Lei, Liu and He, Lin and Ni, Wei},
title = {Angiography-derived versus wire-based fractional flow reserve for guiding coronary revascularization: a meta-analysis of randomized controlled trials},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1969354}
}
EUVIMED